Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
Dexcom (Nadsaq:DXCM) announced today that it received a warning letter from the FDA following inspections of two company ...
Paycom Software (PAYC) shares advanced as KeyBanc upgraded the stock and raised the price target on optimism about sales, ...
Investor's Business Daily on MSN2h
Why Dexcom Is On A Six-Day Losing Spree — But This Analyst Isn't WorriedDexcom stock plunged to a four-month low Monday after the FDA issued a warning letter tied to inspections of two facilities in the U.S.
In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...
The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...
The FDA cited issues with DexCom’s response to prior inspection findings, known as Form 483 observations. The inspections took place at the San Diego facility between October 21 and November 7, 2024, ...
EST DexCom (DXCM) falls 7% to $71.99 after receiving warning letter from FDADiscover the Best Stocks and Maximize Your Portfolio: See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback